Ligand · VMV
VMV · N-[4-({[(6S)-2,4-diamino-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl}amino)benzene-1-carbonyl]-L-glutamic acid
VMV, N-[4-({[(6S)-2,4-diamino-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl]methyl}amino)benzene-1-carbonyl]-L-glutamic acid (C20 H25 N7 O5, 443.5 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every…
- Component
- VMV
- Formula
- C20 H25 N7 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
VMV in 1 structure; the first of them:
- 7JXF · E. coli TSase complex with a bi-substrate reaction intermediate diastereomer analog · VMV A302 · binds ILE79, TRP83, LEU143, ASP169, LEU172, GLY173, PHE176, TYR209 and 5 more
Residues it binds most
ALA 1, ILE 1, LEU 1, ASP 1, GLY 1, LYS 1, PHE 1, TRP 1, TYR 1, VAL 1 (residue and the binding sites it lines).
Found with
- 5HU · 5-hydroxymethyluridine-2'-deoxy-5'-monophosphate
- VNM · (2S)-2-({4-[({(6S)-2,4-diamino-5-[(1-{(2R,4S,5R)-4-hydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-5, 6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl}methyl) amino]benzoyl}amino)pentanedioic acid (non-preferred name)
- NA · Sodium ion
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.